Triple-negative breast cancer (TNBC) is breast cancer that does not have progesterone or estrogen receptors and does not make much, if any, of the HER2 protein. When your tumor cells are tested, they are negative for estrogen, progesterone, and HER2. TNBC may also be called ER/PR negative and HER2 negative.
During a breast biopsy or surgery, a sample of the tumor will be removed. It is sent to a lab and is tested for hormone receptors (estrogen and progesterone) and HER2. These will be listed in your pathology report. If the sample is negative for hormone receptors and HER2, the cancer is called a subtype of breast cancer called triple-negative. Knowing this will help plan your treatment.
A cancer diagnosis can be challenging. Talk to your team about your treatment options and your goals. Below are resources that can help support you and your loved ones.
Triple-Negative Breast Cancer Foundation
Offers education, support/helpline, and online forum.
Living Beyond Breast Cancer
Offers education and a “buddy” program that can match you with another woman who has had a diagnosis of TNBC.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania